Scientists.

Skyline Diagnostics is a pioneering company with a tangible vision on translating discoveries from the laboratory directly to the daily practice of diagnostics. This process starts with synergistic collaborations with outstanding scientists. Step by step we prepare their discoveries for the market through further analysis and clinical validation.

  • Inventors of diagnostic signatures

    As an innovative company, Skyline is actively seeking academic and industrial partners for development of novel diagnostic products. If you have developed a diagnostic signature, published or unpublished, we will screen it in one month against a comprehensive set of criteria.

    Read more >>

  • Erasmus Medical Center

    The Erasmus University Medical Center in Rotterdam is the largest University Hospital and Medical School in The Netherlands. It employs more than 10.000 people, aiming to create for them an optimal environment for the combination of research, education and patient care.

    Read more >>

  • CTMM

    Center for Translational Molecular Medicine (CTMM) is dedicated to the development of medical technologies that enable the design of new and 'personalized' treatments. CTMM focuses on cancer, cardiovascular diseases, neurodegenerative and infectious and autoimmune diseases and wants to facilitate rapid translation of new treatments to the patient.

    Read more >>

  • MIBITON

    The Mibiton (Material Infrastructure Biotechnology Netherlands) foundation stimulates Dutch life sciences entrepreneurship by investing in the Dutch infrastructure. Equipment and special laboratories are used both by research organizations and (young) life science companies. Since 1994, 18 million euro has been invested in about 50 Dutch facilities. 

    Read more >>

  • ANEUDIA

    In 2010, Skyline Diagnostics received a European EuroTransBio subsidy for developing a novel non-invasive diagnostic tool for aneurysms. For this, the ANEUDIA consortium was founded, which includes the Erasmus MC Departments of Bioinformatics and Genetics, the German company Biobase,  the French company QUIDD and Skyline Diagnostics.

    Read more >>

  • CAPITAL BIO

    Also in 2010, a Dutch grant “Subsidieregeling sterktes in innovatie” was acquired for the project “The development of a novel diagnostic platform for leukemia”. Together with the Chinese life science company Capital Bio, the Peking University People’s Hospital, the Erasmus Department MC of Hematology and Skyline Diagnostics, the AMLprofiler will...

    Read more >>

Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com